Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) preparation product apixaban tablets has obtained the temporary approval number of FDA

Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) announced that the company’s new drug brief application for apixaban tablets (anda, i.e. American generic drug application) declared to FDA has been temporarily approved. Apixaban tablets are mainly used to reduce the risk of stroke and systemic embolism.